Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration

Neurology. 1992 Jan;42(1):60-3. doi: 10.1212/wnl.42.1.60.

Abstract

In the planning of MRI protocols to monitor disease activity in multiple sclerosis (MS), the clinical subtype needs to be considered. In this serial gadolinium-enhanced MRI study, we demonstrated differences between patients with early relapsing/remitting MS and benign MS in both the production of new lesions and the occurrence of enhancement.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Contrast Media
  • Gadolinium DTPA
  • Humans
  • Image Enhancement*
  • Magnetic Resonance Imaging*
  • Middle Aged
  • Multiple Sclerosis / diagnosis*
  • Multiple Sclerosis / physiopathology
  • Organometallic Compounds*
  • Pentetic Acid*
  • Recurrence
  • Time Factors

Substances

  • Contrast Media
  • Organometallic Compounds
  • Pentetic Acid
  • Gadolinium DTPA